ABL1 T315I
|
CML
|
ABL1 T315I
|
CML
|
ponatinib Sensitive: A1 - Approval
|
ponatinib Sensitive: A1 - Approval
|
ABL1 T315I
|
ALL
|
ABL1 T315I
|
ALL
|
ponatinib Sensitive: A2 - Guideline
|
ponatinib Sensitive: A2 - Guideline
|
ABL1 T315I
|
CML
|
ABL1 T315I
|
CML
|
dasatinib Resistant: C3 – Early Trials
|
dasatinib Resistant: C3 – Early Trials
|
ABL1 T315I
|
ALL
|
ABL1 T315I
|
ALL
|
dasatinib Resistant: C4 – Case Studies
|
dasatinib Resistant: C4 – Case Studies
|
ABL1 T315I
|
ALL
|
ABL1 T315I
|
ALL
|
imatinib Resistant: C4 – Case Studies
|
imatinib Resistant: C4 – Case Studies
|